PetIQ, Inc. (PETQ)
| Market Cap | 1.25B |
| Revenue (ttm) | 847.62M |
| Net Income (ttm) | -73.34M |
| Shares Out | 26.39M |
| EPS (ttm) | -2.90 |
| PE Ratio | n/a |
| Forward PE | 28.25 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $42.92 |
| Previous Close | $43.77 |
| Change ($) | -0.85 |
| Change (%) | -1.94% |
| Day's Open | 44.00 |
| Day's Range | 42.63 - 44.05 |
| Day's Volume | 638,096 |
| 52-Week Range | 23.01 - 46.00 |
PetIQ (PETQ) delivered earnings and revenue surprises of 200.00% and 20.51%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, May 3, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty clai...
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The number of households with pets is growing, and those pets will need care.
EAGLE, Idaho, April 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the firs...
PetIQ (PETQ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the ne...
Increases Borrowing Capacity by Approximately $109 Million
The pandemic puppy boom is real, and so are sales for these three pet stocks.
PetIQ (PETQ) delivered earnings and revenue surprises of 16.67% and 12.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
EAGLE, Idaho, Feb. 24, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointments of Sheryl Oloughlin...
EAGLE, Idaho, Feb. 23, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will participate in ...
EAGLE, Idaho, Feb. 11, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the fourt...
Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on...
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorP...
EAGLE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will participate in ...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2020 Results - Earnings Call Transcript
PetIQ (PETQ) delivered earnings and revenue surprises of -168.75% and -2.89%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and n...
PetIQ (PETQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PetIQ (PETQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EAGLE, Idaho, Oct. 22, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the third...
Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter
PetIQ shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Stock Upgrades: PetIQ Shows Rising Relative Strength appeared first on Investor's Business Daily.
PetIQ's (PETQ) CEO Cord Christensen on Q2 2020 Results - Earnings Call Transcript
The company achieved record revenue in the second quarter, but is guiding for declines.
Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EAGLE, Idaho, July 23, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the sec...
Expects to Complete Accretive, Strategic Transaction on July 31, 2020
EAGLE, Idaho, June 16, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will participate i...
PetIQ (PETQ) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Proceeds to be Used to Fund Capstar Acquisition Capped Call to Increase Effective Conversion Price to $41.51 (75% Effective Conversion Premium)
EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject to market and other conditions, $125,000,000 aggregate principal ...
EAGLE, Idaho, May 12, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the launch of its telehealth servic...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q1 2020 Results - Earnings Call Transcript
PETQ vs. BSX: Which Stock Is the Better Value Option?
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PETQ vs. MDT: Which Stock Is the Better Value Option?
PetIQ (PETQ) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
Spot and Fluffy are living the good life -- invest so you can too.
EAGLE, Idaho, March 20, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that out of an abundance of cauti...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q4 2019 Results - Earnings Call Transcript
PetIQ (PETQ) delivered earnings and revenue surprises of -100.00% and 14.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Redfin, PetIQ, and Beyond Meat all have upcoming catalysts to propel their shares higher.
EAGLE, Idaho, Feb. 03, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Lauren Olavesse...
Celebrated 20 Wellness Center Openings in December Opened 80 Locations Across 22 States in 2019 at 5 Host Partner Locations Reaffirms 2019 Guidance Presentation at the ICR Conference Today at 11am Ea...
Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and Further Bolsters Manufacturing Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and...
About PETQ
PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of ... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jul 21, 2017 |
| CEO McCord Christensen | Employees 1,015 |
| Stock Exchange NASDAQ | Ticker Symbol PETQ |
Financial Performance
In 2020, PetIQ, Inc.'s revenue was $780.05 million, an increase of 9.95% compared to the previous year's $709.43 million. Losses were -$77.47 million, 576.5% more than in 2019.
Analyst Forecasts
According to 6 analysts, the average rating for PetIQ, Inc. stock is "Strong Buy." The 12-month stock price forecast is 47.60, which is an increase of 10.90% from the latest price.